Operating Income: The income after operating expenses.
Capstone Therapeutics Corp. (CAPS) had Operating Income of $0.43M for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
$21.48M |
|
$-1.38M |
|
$15.48M |
|
$6.00M |
|
$21.05M |
|
|
Operating Income |
$0.43M |
$-1.81M |
|
$-1.38M |
|
$-1.38M |
|
$-1.37M |
|
$-1.37M |
|
$-1.38M |
|
$-1.37M |
|
$0.43M |
|
$1.95M |
|
12.64M |
|
12.64M |
|
$-0.11 |
|
$-0.11 |
|
| Balance Sheet Financials | |
$26.86M |
|
$1.96M |
|
$27.82M |
|
$54.68M |
|
$27.11M |
|
$8.60M |
|
$15.15M |
|
$42.26M |
|
$12.39M |
|
$-7.81M |
|
$12.42M |
|
15.20M |
|
| Cash Flow Statement Financials | |
$-3.18M |
|
$-0.13M |
|
$2.81M |
|
$0.73M |
|
$0.23M |
|
$-0.50M |
|
-- |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.99 |
|
-- |
|
-- |
|
0.41 |
|
2.05 |
|
27.93% |
|
2.01% |
|
2.01% |
|
-- |
|
-6.41% |
|
-6.42% |
|
$-3.27M |
|
-- |
|
-- |
|
-- |
|
0.39 |
|
0.94 |
|
2.29 |
|
39.28 |
|
-11.09% |
|
17.59% |
|
-2.51% |
|
-6.54% |
|
$0.82 |
|
$-0.26 |
|
$-0.25 |
|